Status:
UNKNOWN
Clinical Efficacy and Safety of Fecal Microbiota Transplantation
Lead Sponsor:
Keimyung University Dongsan Medical Center
Conditions:
Fecal Microbiota Transplantation
Eligibility:
All Genders
18-80 years
Brief Summary
Changes in the fecal microbiota are known to be involved in the etiology of several diseases. The purpose of this study is to evaluate the effectiveness and safety of fecal microbiota transplantation ...
Detailed Description
This registry will prospectively enroll 300 patients who undergo fecal microbiota transplantation(FMT) at 3 clinical center (Yeungnam university mecial center, Kyungpook national university hospital, ...
Eligibility Criteria
Inclusion
- Those who have been diagnosed with disease to be studied and do not respond to exist treatments
- Ulcerative colitis, Crohn disease : Patient who does not responding to anti- TNF treatment for more than 3 month.
- Irritable bowel syndrome, Functional dyspepsia : Patient who does not responding to pharmacological therapies and serotonin uptake inhibitor for more than 6 month.
- Recurrent of Refractory CDI, NASH, Obesity : Patient who does not responding to treatment for more than 6 month.
Exclusion
- Neutrophil (\<0.5 x 10\*9/L)
- Leukocytosis (\> 30.0 x 10\*9/L)
- Toxic megacolon confirmed in abdomen Xray
- Pregnant or lactating women
Key Trial Info
Start Date :
December 24 2020
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
December 31 2023
Estimated Enrollment :
100 Patients enrolled
Trial Details
Trial ID
NCT04900051
Start Date
December 24 2020
End Date
December 31 2023
Last Update
May 25 2021
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
KeimyungUniversity
Daegu, Jung-gu, South Korea, 700-712